Chronic Low Back Pain Clinical Trial
Official title:
Effects of Lumbopelvic Manipulation on Neuromuscular Activity of Back and Hip Muscles in Adults With Chronic Low Back Pain
Verified date | October 2016 |
Source | Texas Woman's University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purposes of this study are:
1. To examine the within-day and between-day test-retest reliability of a testing protocol
measuring the back and hip muscles fatigability using EMG median frequency
2. To examine the immediate and the carry-over effects of the lumbopelvic manipulation on
the EMG median frequency of the lumbar multifidus (MULT), gluteus medius (GMED) and
gluteus maximus (GMAX) muscles in patients with chronic low back pain (CLBP)
3. To compare the fatigability levels of the MULT, GMED and GMAX muscles by measuring the
EMG median frequency between the participants who will receive lumbopelvic manipulation.
The research hypotheses are:
1. The testing protocol using EMG median frequency as a fatigue indicator for MULT,GMED and
GMAX muscles will have good (ICC ≥ 0.80) within-day and between-day test-retest
reliability.
2. The fatigability level of the MULT, GMED and GMAX muscles will significantly decrease
immediately after the lumbopelvic manipulation and will be maintained over two to four
days following the manipulation.
3. The fatigability of the MULT, GMED and GMAX muscles will significantly decrease after
the intervention in the manipulation group while no change will occur in the placebo
group.
Status | Completed |
Enrollment | 52 |
Est. completion date | July 2017 |
Est. primary completion date | July 2017 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 60 Years |
Eligibility |
Healthy subjects or the reliability phase: Inclusion Criteria: - Subjects without any history of back problems - Subjects without any known pathology. Exclusion Criteria: - Any serious spinal condition such as tumor, fracture, or infection, - Signs of nerve root compression (i.e. straight leg- raise = 45° or diminished reflexes, sensation or lower extremity strength), - Structural deformity, - Spondylolithesis , - Ankylosing spondylitis - Spinal stenosis, - Osteoporosis, - Previous surgery to the back or the hip, and - Current pregnancy. Subjects with Chronic low back pain for both the reliability and the manipulation phases: Inclusion Criteria: - Participants should be between the age of 20 to 60 years. - Have had complaints of chronic low back pain for at least three months. Exclusion Criteria: - Any serious spinal condition such as tumor, fracture, or infection, - Signs of nerve root compression (i.e. straight leg- raise = 45° or diminished reflexes, sensation or lower extremity strength), - Structural deformity, - Spondylolithesis , - Ankylosing spondylitis - Spinal stenosis, - Osteoporosis, - Previous surgery to the back or the hip, and - Current pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | Texas Woman's University | Dallas | Texas |
Lead Sponsor | Collaborator |
---|---|
Texas Woman's University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Amount of Change in Muscles Endurance | electromyographic (EMG) median frequency will be used to determine the endurance of the gluteus maximums, gluteus medius and the lumbar multifidus muscles. The EMG median frequency will be measured in Hertz (Hz). | Baseline, Immediately, 15-minutes, 30-minutes, and two to four days after the intervention | |
Secondary | Amount of Change in Pain Level | Pain Visual Analogue Scale (VAS) will be used in this study. Participants will be asked to rate their pain level on a 10-cm horizontal line which is marked on the left end "No pain" and on the right end "Extreme pain". Then, the pain level for a specific participant will be determined by measuring the line from the "No pain" end to the mark placed by the participant. | Baseline, immediately, 15-minutes, 30-minutes, and two to four days after the intervention |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03243084 -
Transcranial Alternating Current Stimulation in Back Pain- Pilot Sudy
|
N/A | |
Suspended |
NCT04735185 -
Stem Cells vs. Steroids for Discogenic Back Pain
|
N/A | |
Completed |
NCT03162952 -
RAND Center of Excellence for the Study of Appropriateness of Care in CAM
|
||
Completed |
NCT03240146 -
Pulsed Shortwave Therapy Treatment for Chronic Musculoskeletal Low Back Pain
|
N/A | |
Completed |
NCT05282589 -
Lumbopelvic Manipulation Effects on Fatigue in Chronic Low Back Pain Patients
|
N/A | |
Completed |
NCT03637998 -
Physical Activity on Neurophysiologic Gene Expression Profiles of Chronic Low Back Pain
|
N/A | |
Recruiting |
NCT02289170 -
Clinical Study to Evaluate the Safety and Efficacy of Heating and Cooling Combination Therapeutic Device(OCH-S100)
|
N/A | |
Active, not recruiting |
NCT01944163 -
The IMPACT of a Referral Model for Axial Spondyloarthritis in Young Patients With Chronic Low Back Pain
|
N/A | |
Completed |
NCT02231554 -
Feldenkrais vs Back School for Treating Chronic Low Back Pain: a Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT02063503 -
Identification of Prognostic Indicators for Rehabilitation in Chronic Nonspecific Low Back Pain Patients
|
N/A | |
Terminated |
NCT01620775 -
MR(Magnetic Resonance) Imaging of Neurotransmitters in Chronic Pain
|
N/A | |
Completed |
NCT01704677 -
Lumbar Disc Prosthesis Versus Multidisciplinary Rehabilitation; 8-year Follow-up
|
N/A | |
Completed |
NCT01177280 -
Prevalence of Potential Cytochrome P450 Pharmacokinetic Incident Drug-Drug Interactions Among Chronic Low Back Pain Patients Taking Opioid Analgesics and Associated Economic Outcomes
|
N/A | |
Completed |
NCT01177254 -
Exposure to Potential Cytochrome P450 Pharmacokinetic Drug-Drug Interactions Among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
|
N/A | |
Completed |
NCT01490905 -
A Double Blind Placebo Study to Determine the Effectiveness of Theramine on the Management of Chronic Back Pain
|
Phase 4 | |
Completed |
NCT01177241 -
Cytochrome P450 Pharmacokinetic DDIs Among Patients With Chronic Low Back Pain Taking Opioids
|
N/A | |
Completed |
NCT00984815 -
Safety Study of HZT-501 in Patients Who Require Long-Term Daily Non-steroidal Anti-inflammatory Drug Treatment
|
Phase 3 | |
Completed |
NCT00763321 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 | |
Completed |
NCT00767806 -
A Study for Patient With Chronic Low Back Pain
|
Phase 3 | |
Completed |
NCT00761150 -
Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)
|
Phase 3 |